Skip to main content
PFE
NYSE Life Sciences

Pfizer's LITFULO Hits Phase 3 Goals in Vitiligo, Filing Plans Ahead

Tom Rudovsky · Reported by BusinessWire
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$25.04
Mkt Cap
$143.341B
52W Low
$23.11
52W High
$28.745
52W Position info
8.4% above low
Off High info
13% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

PFE is trading near its 52-week low of $23.11 (8.4% above the low).

Summary

Pfizer's LITFULO met co-primary endpoints in two Phase 3 trials for nonsegmental vitiligo, showing significant facial and total body repigmentation at Week 52. The drug, already approved for severe alopecia areata, now has a clear path to global regulatory filings for a new indication. This expands LITFULO's commercial potential into a chronic autoimmune condition with limited systemic treatment options. The safety profile was consistent with prior experience, with no new signals. The news adds to a string of positive pipeline updates from Pfizer this year, including advances in oncology and obesity. Full data will be presented at a future medical meeting, which could further define the drug's competitive positioning.

At the time of this announcement, PFE was trading at $25.04 on NYSE in the Life Sciences sector, with a market capitalization of approximately $143.3B. The 52-week trading range was $23.11 to $28.75. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

PFE - Latest Insights

PFE
Nov 18, 2026, 7:20 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $28.28
Real-time Price: $27.55 info
Change: -$0.730 (-3%) info
Market Cap: $156.974B info
PFE
Nov 16, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $29.12
Real-time Price: $27.55 info
Change: -$1.57 (-5%) info
Market Cap: $156.974B info
PFE
Nov 13, 2026, 3:19 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $28.85
Real-time Price: $27.55 info
Change: -$1.30 (-5%) info
Market Cap: $156.974B info
PFE
Nov 11, 2026, 4:30 PM EST
Source: BusinessWire
Importance Score:
7
Price at Filing: $29.45
Real-time Price: $27.55 info
Change: -$1.90 (-6%) info
Market Cap: $156.974B info
PFE
Nov 03, 2026, 8:19 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $30.66
Real-time Price: $27.55 info
Change: -$3.11 (-10%) info
Market Cap: $156.974B info